Clinical trials recruiting in Hunan, China
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 2Phase 2 4Phase 3 1Not applicable 2
Conditions recruiting in Hunan, China
Recruiting trials in Hunan, China
- A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
- A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
- Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Chinese Psoriasis Real World Evidence Research
- Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
Common questions
How many clinical trials are recruiting in Hunan, China?
7 recruiting trials have at least one study site in Hunan, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.